Physician profile
Colbert Chavez
NPI 1326187345
$4,874.28
in general payments reported to CMS, 2019-2025
10 companies · $2,576 in 2025
The $2,576 reported for 2025 was more than what 90% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $138 · 2023: $227 · 2024: $1,934 · 2025: $2,576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,321 · Travel and Lodging: $1,331 · Consulting Fee: $1,000 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,320.67 |
| Travel and Lodging | $1,331.04 |
| Consulting Fee | $1,000.00 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,596.73 | 2023-2025 | Inspire |
| Itamar Medical INC | $1,110.63 | 2023-2025 | Watchpatone |
| Harmony Biosciences LLC | $466.34 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $234.18 | 2023-2025 | |
| Axsome Therapeutics, INC. | $166.70 | 2023-2025 | Sunosi |
| Lilly USA, LLC | $136.67 | 2025 | Zepbound, Mounjaro |
| Teva Pharmaceuticals USA, INC. | $76.46 | 2023-2024 | Ajovy |
| Avadel Cns Pharmaceuticals, LLC | $50.99 | 2024-2025 | Lumryz |
| Resmed Corp | $21.90 | 2025 | |
| Gilead Sciences, INC. | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colbert Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.